These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6378988

  • 1. Diltiazem in the treatment of mild or moderate essential hypertension. Comparison with metoprolol in a crossover double-blind trial.
    Trimarco B, DeLuca N, Ricciardelli B, Volpe M, Veniero A, Cuocolo A, Cicala M.
    J Clin Pharmacol; 1984; 24(5-6):218-27. PubMed ID: 6378988
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension.
    Leonetti G, Mazzola C, Boni S, Guffanti E, Meani A, Zanchetti A.
    Eur J Clin Pharmacol; 1986; 30(6):637-40. PubMed ID: 3533561
    [Abstract] [Full Text] [Related]

  • 5. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
    Myburgh DP, Gordon NF.
    Am J Cardiol; 1987 Nov 01; 60(13):1092-5. PubMed ID: 3314458
    [Abstract] [Full Text] [Related]

  • 6. Diltiazem compared with metoprolol as add-on-therapies to diuretics in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
    Thulin T, Hedner T, Gustafsson S, Olsson SO.
    J Hum Hypertens; 1991 Apr 01; 5(2):107-14. PubMed ID: 2072368
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of diltiazem sustained-release formulation and metoprolol on ambulatory blood pressure and plasma lipoproteins.
    Lacourcière Y, Poirier L, Boucher S, Spenard J.
    Clin Pharmacol Ther; 1990 Sep 01; 48(3):318-24. PubMed ID: 2401129
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of diltiazem and metoprolol in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
    Hedner T, Thulin T, Gustafsson S, Olsson SO.
    Eur J Clin Pharmacol; 1990 Sep 01; 39(5):427-33. PubMed ID: 2076733
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
    Pool PE, Massie BM, Venkataraman K, Hirsch AT, Samant DR, Seagren SC, Gaw J, Salel AF, Tubau JF.
    Am J Cardiol; 1986 Feb 01; 57(4):212-7. PubMed ID: 3511660
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diltiazem versus propranolol in essential hypertension: responses of rest and exercise blood pressure and effects on exercise capacity.
    Szlachcic J, Hirsch AT, Tubau JF, Vollmer C, Henderson S, Massie BM.
    Am J Cardiol; 1987 Feb 15; 59(5):393-9. PubMed ID: 3812308
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
    Pandhi P, Sahai J, Wahi PL, Sharma BK, Sharma PL.
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar 15; 25(3):163-5. PubMed ID: 3549583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.